Ergomed

Ergomed is a global provider of specialized clinical research services, offering end-to-end clinical development, pharmacovigilance and GxP audit support to pharmaceutical and biotechnology companies. Founded in 1997 and headquartered in Guildford, UK, with a US headquarters in Raleigh, North Carolina, the company employs more than 2,900 professionals and operates in around 100 countries.

Its work is organised through specialized businesses: Ergomed Clinical Research delivers clinical development services, PrimeVigilance handles pharmacovigilance, and ADAMAS Consulting provides GxP audit services. Ergomed CARE™ is a proprietary solution for patient-centric trial management. The company manages Phase I–IV studies, with particular depth in oncology, rare diseases and complex trials.

Scale figures include more than 600 Phase I–IV clinical trials managed, over 330 oncology studies and more than 200 rare disease trials conducted, and over 275,000 patient cases processed each year. The organisation runs a flat structure intended to support agility and responsiveness on demanding clinical projects.